The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $14.01

Today's change0.00 0.00%
Updated October 23 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $14.01

Today's change0.00 0.00%
Updated October 23 4:00 PM EDT. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc closed at (U.S.)$14.01.

Over the last five days, shares have gained 1.37% and are currently 3.04% off of the 52-week high. Shares have underperformed the S&P 500 by 7.53% during the last year.

Key company metrics

  • Open(U.S.) $14.08
  • Previous close(U.S.) $14.01
  • High(U.S.) $14.20
  • Low(U.S.) $14.00
  • Bid / Ask(U.S.) $9.12 / (U.S.) $0.00
  • YTD % change+37.22%
  • Volume1,436,784
  • Average volume (10-day)1,268,423
  • Average volume (1-month)2,184,821
  • Average volume (3-month)2,848,142
  • 52-week range(U.S.) $9.80 to (U.S.) $14.45
  • Beta1.38
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward22.81×
  • Forward PEG1.27×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.05
Updated October 23 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-8.96%

Although this company's net profit margin is negative, it is above the industry average and implies that Allscripts Healthcare Solutions Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.01%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue426413425392
Total other revenue--------
Total revenue426413425392
Gross profit187179186166
Total cost of revenue239235239226
Total operating expense550402413376
Selling / general / administrative11211111599
Research & development46494845
Depreciation / amortization87115
Interest expense (income), net operating--------
Unusual expense (income)145000
Other operating expenses, total--------
Operating income-123111217
Interest income (expense), net non-operating-19-19-20-18
Gain (loss) on sale of assets--------
Other--------
Income before tax-144-8-12-2
Income after tax-143-930
Income tax, total-10-15-3
Net income-143-930
Total adjustments to net income-11-11-10-10
Net income before extra. items-143-930
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-154-20-7-10
Inc. avail. to common incl. extra. items-154-20-7-10
Diluted net income-154-20-7-10
Dilution adjustment0------
Diluted weighted average shares181181183186
Diluted EPS excluding extraordinary itemsvalue per share-0.85-0.11-0.04-0.05
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.33-0.11-0.04-0.05